Circa Survive - Two Dreams [Clear w/ Red, White & Blue Splatter + Yellow w/ Red, White & Blue Splatter]

Format: 2 x LP
ICPN: 4050538713220
Release Date: 13 Jan 2023
Genre: Indie/Alternative

Tracklist:
Side 1
1. Imposter Syndrome
2. Drift
3. Our Last Shot

Side 2
1. Even Better
2. Gone For Good
3. Sleep Well

Side 3
1. Electric Moose
2. Curitiba
3. Late Nap

Side 4
1. Discount on Psychic Readings
2. Die On The West Coast
3. Buzzhenge

Whether intentional or not, Philadelphia’s Circa Survive have become experts on that critical second word of their band name. With six full-length records and three EPs behind them, the beloved alt-prog/post-hardcore giants are entering their 17th year together amid global upheaval and personal renaissance, creating together while navigating through one of the most unstable chapters in American history. It’s a necessarily existential period, where that one imperative rises to the top: survive.
In early 2020, the band was forced to reschedule the tenth anniversary tour for their ground-breaking 2010 LP Blue Sky Noise. Pushing off the tour—now slated for 2022—and delaying plans for a new record has ushered in a new chapter for Circa Survive.

Two Dreams, the forthcoming seventh full-length record from Philadelphia’s Circa Survive, is a project of dual realities in both theory and practice. The 12-track record comprises two individual six-song EPs, titled A Dream About Love and A Dream About Death. The dreams in question aren’t the idyllic material of sleep, but a much more tangible, dark surrealism. They’re the twin experiences of vocalist Anthony Green after relapsing and overdosing on heroin during the writing of the album.

With Two Dreams, Circa Survive aims higher in both collective spirit and individual practice. After nearly two decades of international tours and festival mainstages, the band has regrouped to protect one another and their work. They’re playing the long-game. “I want to make 100 more records,” laughs Green. But now, the goal isn't to simply survive. It’s to thrive.